The Past, Present and Future of the Total Artificial Heart

The Texas Heart Institute

W. Cohn, O. Frazier

Pulmonary Hypertension: The Basic Essential Facts

Mount Sinai Advanced Heart Disease Symposium 2017

M. Trivieri

High-Risk Cardiac Surgery and Pre-Op Optimization with Impella Base …

St. Louis Shock & Heart Failure Symposium 2022

J. Leidenfrost

Hemodynamic vs. Hemo-Metabolic Shock: Redefining Shock Profiles

The Cardiogenic Shock Working Group

N. Kapur

Contemporary Management of Cardiogenic Shock: Updates in 2022

Mount Sinai Advanced Innovations in Heart Failure

D. Baran

Acute Kidney Injury After LVAD Implantation

The Texas Heart Institute

K. Timmins-Vollmers

Use of MCS in Management of Acute Post-MI VSD

Houston Shock Symposium

D. Ramini

Pulmonary Arterial Hypertension: Who, When and How to Treat?

Scripps Health: Fourth Annual Clinical Advances in the Diagnosis and Management of Pulmonary Hypertension

R. Mohan

Cardiogenic Shock: Should IABP or PVADs Be Used in Cardiogenic Shock?

American Heart & Vascular Institute

M. Ansari

Cardiac Surgery Case: Post Cardiotomy Shock Requiring Mechanical Cir…

The 10th Annual Western New England Acute Cardiology Conference

K. Wanamaker

Timing and Choice of Percutaneous Mechanical Circulatory Support (pM…

UChicago Medicine

S. Nathan

The Other Option for Hemodynamic Support in High Risk PCI

Joseph Thomas

Pulmonary Hypertension Due to Lung Disease / Chronic Pulmonary Embol…

Scripps Health

K. Fan